[1] Palmgren E, Widgren B, Aurell M, et al. Increased renal vascular sensitivity to angiotensin Ⅱ in hypertension is due to decreased response to prostaglandins[J]. J Hypertens, 2003, 21(5): 969-76. [2] 刘治全.盐敏感性高血压[A].见:刘力生.高血压[M].北京:人民卫生出版社,2001.512-25. [3] Johnson RJ, Herrera-Acosta J, Schreiner GF, et al. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension [J]. N Engl J Med, 2002, 346(12): 913-23. [4] Chiolero A, Wurzner G, Bumier M. Renal determinants of the salt sensitivity of blood pressure [J]. Nephrol Dial Transplant, 2001, 16(3): 452-8. [5] Cheng HF, Harris RC. Cyclooxygenases, the kidney, and hypertension [J]. Hypertension, 2004, 43(3): 525-30. [6] Guidelines Subcommittee. 1999 World Health Organization -International Society of Hypertension: Guidelines for the management of hypertension[J]. J hypertens, 1999, 17(2): 151-83. [7] Sullivan JM. Salt sensitivity: definition, conception, methodology and long-term issues[J]. Hypertension, 1991, 17(1 Suppl): 161-8. [8] 刘治全.盐与高血压[M].北京:北京医科大学协和医科大学联合出版社,1997.4. [9] Laffer CL, Laniado-Schwartzman M, Wang MH, et al. Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertension[J]. Circulation,2003, 107(4): 574-8. [10] Laffer CL, Laniado-Schwartzman M, Nasjletti A, et al. 20-HETE and circulating insulin in essential hypertension with obesity [J].Hypertension, 2004, 43(2): 388-92. [11] Strazzullo P, Galletti F, Barba G. Altered renal handling of sodium in human hypertension: short review of the evidence [J].Hypertension, 2003, 41(5): 1000-5. [12] Vasdev S, Gill V, Longerich L, et al. Salt-induced hypertension in WKY rats: prevention by alpha-lipoic acid supplementation [J]. Mol Cell Biochem, 2003,254(1-2):319-26. [13] Ogihara T, Asano T, Fujita T. Contribution of salt intake to insulin resistance associated with hypertension [J]. Life Sci, 2003, 73 (5):509-23. [14] Angoli GC, Borgatti R, Cacciari M, et al. Renal prostanoids: physiological relevance in healthy salt-depleted women [J]. Clin Physiol,1999(1), 19:22-31. [15] Imig, JD, Kitiyakara C, Wilcox CS. Arachidonate metabolites[A].Seldin DE, Giebish G. The Kidney: Physiology and Pathophysiology [M]. New York: Lippincott Williams & Wilkens,2000. 875-89. [16] Eras J, Perazella MA. NSAIDs and the kidney revisited: are selective cyclooxygenase-2 inhibitors safe[J] ? Am J Med Sci, 2001, 321(3):181-90. [17] SilldorffEP, Hilbun LR, Pallone TL. Angiotensin Ⅱ constriction of rat vasa recta is partially thromboxane dependent hypertension [J].2002,40(4): 541-6. [18] Wilcox CS, Welch WJ. Thromboxane synthase and TP receptor mRNA in rat kidney and brain: effects of salt intake and ANG Ⅱ [J].Am J Physiol Renal Physiol, 2003, 284(3): F525-31. [19] Lariviere R, Moreau C, Rodrigue ME, et al. Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats [J]. Prostaglandins Leukot Essent Fatty Acids, 2004, 71(2): 103-9. [20] Meng S, Cason GW, Gannon AW, et al. Oxidative stress in Dah1 salt-sensitive hypertension [J]. Hypertension, 2003, 41 (6): 1346-52. [21] Reckelhoff JF, Romero JC. Role of oxidative stress in angiotensininduced hypertension [J]. Am J Physiol Regul Integr Comp Physiol,2003, 284(4): R893-912. |